Differences in sarcopenia prevalence between upper-body and lower-body based EWGSOP2 muscle strength criteria: the Tromsø study 2015–2016

BACKGROUND: The European Working Group on Sarcopenia in Older People (EWGSOP2) recommends grip strength and chair stand tests to be used as primary defining measures. It is unclear how either test affects prevalence estimates. METHODS: This cross-sectional study involved 3498 community-dwelling part...

Full description

Bibliographic Details
Published in:BMC Geriatrics
Main Authors: Johansson, Jonas, Strand, Bjørn Heine, Morseth, Bente, Hopstock, Laila Arnesdatter, Grimsgaard, Sameline
Format: Text
Language:English
Published: BioMed Central 2020
Subjects:
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654146/
https://doi.org/10.1186/s12877-020-01860-w
id ftpubmed:oai:pubmedcentral.nih.gov:7654146
record_format openpolar
spelling ftpubmed:oai:pubmedcentral.nih.gov:7654146 2023-05-15T18:34:32+02:00 Differences in sarcopenia prevalence between upper-body and lower-body based EWGSOP2 muscle strength criteria: the Tromsø study 2015–2016 Johansson, Jonas Strand, Bjørn Heine Morseth, Bente Hopstock, Laila Arnesdatter Grimsgaard, Sameline 2020-11-10 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654146/ https://doi.org/10.1186/s12877-020-01860-w en eng BioMed Central http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654146/ http://dx.doi.org/10.1186/s12877-020-01860-w © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. CC0 PDM CC-BY BMC Geriatr Research Article Text 2020 ftpubmed https://doi.org/10.1186/s12877-020-01860-w 2020-11-15T01:48:10Z BACKGROUND: The European Working Group on Sarcopenia in Older People (EWGSOP2) recommends grip strength and chair stand tests to be used as primary defining measures. It is unclear how either test affects prevalence estimates. METHODS: This cross-sectional study involved 3498 community-dwelling participants (40–84 years) from the 7th Tromsø Study survey (2015–2016). We used grip strength, five-repetition chair stands, four-meter Walk Speed Test, Timed-Up-and-Go (TUG) and Dual-Energy X-ray Absorptiometry measurements. Data were analyzed using multiple linear regression models and ROC-curves. RESULTS: Probable and confirmed sarcopenia prevalence was 1.3 and 4.4% based on grip strength and chair stands, respectively. There was very low agreement between grip strength and chair stand cut-offs (κ = 0.07), with only 4.3% of participants defined as having probable sarcopenia overlapping in the two criteria. Participants with grip strength-based sarcopenia had lower mean height, weight, waist circumference, and appendicular lean mass relative to body height (ALM(height)(2)) than non-sarcopenic participants (all p < 0.001), after adjusting for multiple covariates. Conversely, participants with chair stand-based sarcopenia had similar height, higher weight, waist circumference and body fat% compared to non-sarcopenic participants (all p < 0.05). Area-under-curves (AUCs) for TUG-time were significantly larger when using chair stand instead of grip strength cut-offs (0.86, 95% CI 0.84–0.89 vs. 0.75, 95% CI 0.69–0.83). CONCLUSIONS: Using chair stands instead of grip strength more than doubled probable sarcopenia prevalence across all ages. The two measures defined individuals of contradictory anthropometrics, body composition, and dissimilar physical function to have probable sarcopenia. Researchers should further evaluate the consequences of using different strength measures in the EWGSOP2 definition to classify sarcopenia. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at ... Text Tromsø PubMed Central (PMC) Tromsø BMC Geriatrics 20 1
institution Open Polar
collection PubMed Central (PMC)
op_collection_id ftpubmed
language English
topic Research Article
spellingShingle Research Article
Johansson, Jonas
Strand, Bjørn Heine
Morseth, Bente
Hopstock, Laila Arnesdatter
Grimsgaard, Sameline
Differences in sarcopenia prevalence between upper-body and lower-body based EWGSOP2 muscle strength criteria: the Tromsø study 2015–2016
topic_facet Research Article
description BACKGROUND: The European Working Group on Sarcopenia in Older People (EWGSOP2) recommends grip strength and chair stand tests to be used as primary defining measures. It is unclear how either test affects prevalence estimates. METHODS: This cross-sectional study involved 3498 community-dwelling participants (40–84 years) from the 7th Tromsø Study survey (2015–2016). We used grip strength, five-repetition chair stands, four-meter Walk Speed Test, Timed-Up-and-Go (TUG) and Dual-Energy X-ray Absorptiometry measurements. Data were analyzed using multiple linear regression models and ROC-curves. RESULTS: Probable and confirmed sarcopenia prevalence was 1.3 and 4.4% based on grip strength and chair stands, respectively. There was very low agreement between grip strength and chair stand cut-offs (κ = 0.07), with only 4.3% of participants defined as having probable sarcopenia overlapping in the two criteria. Participants with grip strength-based sarcopenia had lower mean height, weight, waist circumference, and appendicular lean mass relative to body height (ALM(height)(2)) than non-sarcopenic participants (all p < 0.001), after adjusting for multiple covariates. Conversely, participants with chair stand-based sarcopenia had similar height, higher weight, waist circumference and body fat% compared to non-sarcopenic participants (all p < 0.05). Area-under-curves (AUCs) for TUG-time were significantly larger when using chair stand instead of grip strength cut-offs (0.86, 95% CI 0.84–0.89 vs. 0.75, 95% CI 0.69–0.83). CONCLUSIONS: Using chair stands instead of grip strength more than doubled probable sarcopenia prevalence across all ages. The two measures defined individuals of contradictory anthropometrics, body composition, and dissimilar physical function to have probable sarcopenia. Researchers should further evaluate the consequences of using different strength measures in the EWGSOP2 definition to classify sarcopenia. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at ...
format Text
author Johansson, Jonas
Strand, Bjørn Heine
Morseth, Bente
Hopstock, Laila Arnesdatter
Grimsgaard, Sameline
author_facet Johansson, Jonas
Strand, Bjørn Heine
Morseth, Bente
Hopstock, Laila Arnesdatter
Grimsgaard, Sameline
author_sort Johansson, Jonas
title Differences in sarcopenia prevalence between upper-body and lower-body based EWGSOP2 muscle strength criteria: the Tromsø study 2015–2016
title_short Differences in sarcopenia prevalence between upper-body and lower-body based EWGSOP2 muscle strength criteria: the Tromsø study 2015–2016
title_full Differences in sarcopenia prevalence between upper-body and lower-body based EWGSOP2 muscle strength criteria: the Tromsø study 2015–2016
title_fullStr Differences in sarcopenia prevalence between upper-body and lower-body based EWGSOP2 muscle strength criteria: the Tromsø study 2015–2016
title_full_unstemmed Differences in sarcopenia prevalence between upper-body and lower-body based EWGSOP2 muscle strength criteria: the Tromsø study 2015–2016
title_sort differences in sarcopenia prevalence between upper-body and lower-body based ewgsop2 muscle strength criteria: the tromsø study 2015–2016
publisher BioMed Central
publishDate 2020
url http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654146/
https://doi.org/10.1186/s12877-020-01860-w
geographic Tromsø
geographic_facet Tromsø
genre Tromsø
genre_facet Tromsø
op_source BMC Geriatr
op_relation http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654146/
http://dx.doi.org/10.1186/s12877-020-01860-w
op_rights © The Author(s) 2020
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
op_rightsnorm CC0
PDM
CC-BY
op_doi https://doi.org/10.1186/s12877-020-01860-w
container_title BMC Geriatrics
container_volume 20
container_issue 1
_version_ 1766219308666454016